UBS Group AG - ASTRIA THERAPEUTICS INC ownership

ASTRIA THERAPEUTICS INC's ticker is and the CUSIP is 04635X102. A total of 33 filers reported holding ASTRIA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of ASTRIA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$96,435
-21.7%
12,927
-12.6%
0.00%
Q2 2023$123,167
+246.6%
14,786
+453.4%
0.00%
Q1 2023$35,538
+59130.0%
2,672
+66700.0%
0.00%
Q4 2022$60
-99.8%
4
-99.9%
0.00%
Q3 2022$29,0003,262
+12948.0%
0.00%
Q2 2022$0
-100.0%
25
-99.2%
0.00%
Q4 2021$18,000
-33.3%
3,247
+7.9%
0.00%
Q3 2021$27,0003,0080.00%
Other shareholders
ASTRIA THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Altium Capital Management LP 1,355,372$20,181,48910.26%
Fairmount Funds Management LLC 1,901,397$28,311,8014.49%
Tri Locum Partners LP 651,330$9,698,0003.92%
Vivo Capital, LLC 1,681,199$25,0332.88%
Ghost Tree Capital, LLC 450,000$6,701,0002.86%
Affinity Asset Advisors, LLC 472,482$7,035,2572.76%
Ikarian Capital, LLC 675,176$10,053,3702.42%
Cormorant Asset Management, LP 1,650,000$24,5691.64%
Logos Global Management LP 864,960$12,879,2541.51%
SPHERA FUNDS MANAGEMENT LTD. 469,340$6,988,4731.50%
View complete list of ASTRIA THERAPEUTICS INC shareholders